Europe
NOX-A12 penetrates cancer tissue and triggers immune response in both tumor types with greater target neutralization correlated with improved immune profiles in the tumor microenvironment
HERA-CD27L Enhances T Cell Activation and Induces Anti-Tumor Immunity
Epigenomics AG today announced that the U.S. Congress urges the Centers of Medicare & Medicaid Services (CMS) to consider coverage of colorectal cancer screening blood tests as part of the approved 2019 Health and Human Services (HHS) Appropriations Bill.
The use of multiple, potentially costly, drugs during combination therapy all contributes to the high costs in oncology. DO you know why does immunotherapy cost so much?
Medherant, a developer of innovative transdermal drug delivery treatments for pain and CNS diseases, has been awarded a Medicines Manufacturing Grant by Innovate UK.
Ergomed plc today announces two Board changes with immediate effect.
PTC Therapeutics announced interim data from Part 1 of its open-label clinical trials, FIREFISH and SUNFISH, of risdiplam for Type 1, 2 and 3 spinal muscular atrophy in collaboration with Genentech.
HEXCEL has officially opened its new carbon fiber plant at the Les Roches-Roussillon Chemicals Industry Platform in Isère, France.
This groundbreaking software is set to transform the market for ion exchange process design
Biomedical engineers from Karl Landsteiner University of Health Sciences in Krems launch project focused on 3D printing of tissue models
PRESS RELEASES